KING OF PRUSSIA, PA — XyloCor Therapeutics has dosed the first patient in its Phase 2b EXACT-2 trial evaluating XC001 (encoberminogene rezmadenovec), a novel gene therapy designed to help patients ...

Andrews JL, Shirley PS, Iverson WO, Sherer AD, Markovits JE, King L, Lyons RM, Kaleko M, Connelly S. Evaluation of the duration of human factor VIII expression in nonhuman primates after systemic ...

The biotech firm eliminated the need for surgical administration in the study by using an infusion catheter system in a cardiac cath lab.

Analysis from the Thrombotic Thrombocytopenia Syndrome Consortium has provided critical insights into the rare but serious ...

Wang H and Lieber A (2006) A helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassette.

The doctor explained how climate changes can trigger viral infections and affect children and elderly people severely.

AIIMS experts confirm no link between COVID-19 vaccines and sudden youth deaths, citing studies and reaffirming vaccine safety and effectiveness.

We have previously developed a novel adenovirus vector (Adv) that targeted tumor tissues/vasculatures after systemic administration. The surface of this Adv is conjugated with CGKRK tumor homing ...

Researchers from Purdue University and the U.S. Centers for Disease Control and Prevention have recently developed a novel influenza vaccine candidate that uses a bovine adenoviral (BAd) vector to ...